{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:12:05Z","timestamp":1788901925340,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82425049"],"award-info":[{"award-number":["82425049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372813"],"award-info":[{"award-number":["82372813"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273074"],"award-info":[{"award-number":["82273074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["22ZR1477900"],"award-info":[{"award-number":["22ZR1477900"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["22QA1411600"],"award-info":[{"award-number":["22QA1411600"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2024ZD0520506"],"award-info":[{"award-number":["2024ZD0520506"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.hbpd.2026.08.005","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:39:55Z","timestamp":1787269195000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of the APASL score: A laboratory-based prognostic model for survival prediction in patients undergoing hepatectomy for hepatocellular carcinoma"],"prefix":"10.1016","author":[{"given":"Dong-Xu","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Da","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ze","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Da","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Kang","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Qing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric CH","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2026.08.005_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0002","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0003","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"European association for the study of the liver. EASL clinical practice guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0004","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: a review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.iliver.2024.100083","article-title":"Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma","volume":"3","author":"Wang","year":"2024","journal-title":"ILIVER"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0006","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/SLA.0000000000000710","article-title":"Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis","volume":"261","author":"Tabrizian","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0007","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy","volume":"38","author":"Imamura","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0008","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/cas.16194","article-title":"Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: current status, challenges and opportunities","volume":"115","author":"Wang","year":"2024","journal-title":"Cancer Sci"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0009","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/jhep.2001.27219","article-title":"Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the liver italian program","volume":"34","author":"Ueno","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0011","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1245\/s10434-022-11454-y","article-title":"Clinical features of recurrence after hepatic resection for early-stage hepatocellular carcinoma and long-term survival outcomes of patients with recurrence: a multi-institutional analysis","volume":"29","author":"Yao","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0012","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s11605-022-05435-5","article-title":"A web-based prediction model for estimating the probability of post-hepatectomy major complications in patients with hepatocellular carcinoma: a multicenter study from a hepatitis B virus-endemic area","volume":"26","author":"Kong","year":"2022","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0013","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.21037\/atm-20-1421","article-title":"A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma","volume":"8","author":"Sun","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0014","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamasurg.2018.4334","article-title":"Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China","volume":"154","author":"Xu","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0015","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.surg.2022.05.023","article-title":"Risk factors and long-term prognosis of beyond-Milan recurrence after hepatectomy for BCLC stage 0\/A hepatocellular carcinoma: a large-scale multicenter study","volume":"172","author":"Feng","year":"2022","journal-title":"Surgery"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0016","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3350\/cmh.2022.0212","article-title":"Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region","volume":"29","author":"Kim","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106843","article-title":"Prothrombin induced by vitamin K absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: a retrospective cohort study","volume":"105","author":"Wang","year":"2022","journal-title":"Int J Surg"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0018","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1245\/s10434-023-14525-w","article-title":"Prognostic value of serum \u03b1-fetoprotein level as an important characteristic of tumor biology for patients undergoing liver resection of early-stage hepatocellular carcinoma (BCLC Stage 0\/A): a large multicenter analysis","volume":"31","author":"Yao","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0019","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2217\/bmm-2020-0474","article-title":"Clinical utility of serum biomarkers for hepatocellular carcinoma","volume":"15","author":"Xu","year":"2021","journal-title":"Biomark Med"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0020","doi-asserted-by":"crossref","first-page":"15447","DOI":"10.1007\/s13277-016-5443-x","article-title":"Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma","volume":"37","author":"Xing","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0021","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/JHC.S289840","article-title":"Association of postoperative biomarker response with recurrence and survival in patients with hepatocellular carcinoma and high alpha-fetoprotein expressions (>400 ng\/ml)","volume":"8","author":"Liang","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.gassur.2025.102038","article-title":"Tumor biology characteristics score based on alpha-fetoprotein and protein induced by vitamin K absence or antagonist II as a predictor for recurrence and survival after curative resection for hepatocellular carcinoma: a multicenter cohort study","volume":"29","author":"Wang","year":"2025","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0023","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00432-010-0935-3","article-title":"A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort","volume":"137","author":"Yang","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0024","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.hpb.2022.09.002","article-title":"Prospective validation of the Eastern Staging in predicting survival after surgical resection for patients with hepatocellular carcinoma: a multicenter study from China","volume":"25","author":"Yang","year":"2023","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.amjsurg.2024.01.009","article-title":"Development and validation of prealbumin-bilirubin score (preALBI score) for predicting long-term survival after hepatectomy for hepatocellular carcinoma: a multicenter analysis versus ALBI score","volume":"232","author":"Li","year":"2024","journal-title":"Am J Surg"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0026","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0027","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jgh.13608","article-title":"ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD era","volume":"32","author":"Liu","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0028","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/SLA.0000000000006235","article-title":"Perioperative changes in serum transaminase levels: impact on postoperative morbidity after liver resection of hepatocellular carcinoma","volume":"281","author":"Wang","year":"2025","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0029","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1245\/s10434-024-16705-8","article-title":"Perioperative changes in serum transaminases levels predicts long-term survival following liver resection of hepatocellular carcinoma","volume":"32","author":"Lu","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0031","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0032","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma","volume":"146","author":"Yau","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0033","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s005350300038","article-title":"Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan integrated staging score (JIS score)","volume":"38","author":"Kudo","year":"2003","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.09.001","article-title":"A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma","volume":"45","author":"Shi","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0035","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2018.08.027","article-title":"Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection","volume":"69","author":"Chan","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0036","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2217\/bmm-2018-0414","article-title":"Clinical performance of \u03b1-L-fucosidase for early detection of hepatocellular carcinoma","volume":"13","author":"Xing","year":"2019","journal-title":"Biomark Med"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0037","article-title":"Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study","volume":"15","author":"Lin","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0038","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4251\/wjgo.v13.i5.351","article-title":"Biomarkers for hepatocellular carcinoma based on body fluids and feces","volume":"13","author":"Guan","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0039","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4251\/wjgo.v13.i4.197","article-title":"Early diagnosis and therapeutic strategies for hepatocellular carcinoma: from bench to bedside","volume":"13","author":"Guan","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clinbiochem.2018.02.007","article-title":"Serum ARCHITECT PIVKA-II reference interval in healthy Chinese adults: sub-analysis from a prospective multicenter study","volume":"54","author":"Yan","year":"2018","journal-title":"Clin Biochem"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0041","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.hbpd.2018.09.009","article-title":"Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: a systematic review with meta-analysis","volume":"17","author":"Xing","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0042","doi-asserted-by":"crossref","first-page":"9929","DOI":"10.2147\/CMAR.S275307","article-title":"Preoperative inversed albumin-to-globulin ratio predicts worse oncologic prognosis following curative hepatectomy for hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0043","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijsu.2016.10.033","article-title":"Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection","volume":"36","author":"Wu","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.hbpd.2026.08.005_bib0044","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.hbpd.2023.12.004","article-title":"Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score","volume":"24","author":"Sun","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S149938722600127X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S149938722600127X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:49:16Z","timestamp":1788900556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S149938722600127X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":44,"alternative-id":["S149938722600127X"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2026.08.005","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of the APASL score: A laboratory-based prognostic model for survival prediction in patients undergoing hepatectomy for hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2026.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}